| Literature DB >> 24434288 |
Abstract
Molecular imaging is a multimodality discipline for noninvasively visualizing biologic processes at the subcellular level. Clinical applications of radionuclide-based molecular imaging for breast cancer continue to evolve. Whole-body imaging, with scintimammography and PET, and newer dedicated breast imaging systems are reviewed. The potential clinical indications and the challenges of implementing these emerging technologies are presented.Entities:
Keywords: PET; PET/CT; breast; breast cancer; breast-specific γ imaging; molecular imaging; oncology; positron-emission mammography; positron-emission tomography; radiopharmaceuticals
Mesh:
Substances:
Year: 2014 PMID: 24434288 DOI: 10.2967/jnumed.113.126102
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057